Friday 11th December 2020
Pfizer / Biontech vaccine
US experts vote for FDA emergency approval
It is already being vaccinated in Great Britain, the EU is under review, and its use is imminent in the USA: the corona vaccine from Biontech and Pfizer. A commission from the US FDA recommends emergency approval.
A commission of experts from the US FDA has recommended emergency approval of the corona vaccine from the Mainz-based company Biontech and its US partner Pfizer. The panel voted in a public meeting for approval in the USA, which could now be decided within a few days.
The vote of the expert committee is not binding. But everything speaks for the fact that the Biontech vaccine will soon receive emergency approval. The FDA said on Tuesday that it classified the vaccine as safe and effective. On Wednesday, the US Department of Health announced that it would use the Biontech vaccine in hospitals and old people’s homes from the beginning of next week.
The vaccine is already approved in the UK, Canada and other countries. In the EU, the examination for an emergency approval is ongoing.
The Biontech vaccine is based on what is known as mRNA technology. In contrast to conventional vaccines, the pathogen or parts of the pathogen are not injected, but the genetic blueprint of the pathogen is passed on so that the body produces the antigen itself and develops an immune response.
In numerical terms, the USA is the country hardest hit by the corona pandemic in the world. More than 15 million infections with the coronavirus have already been detected here, and more than 289,000 infected people died. The newly elected President Joe Biden, who will take office on January 20, wants to have 100 million citizens vaccinated against Corona in the 100 days that follow.